HeimLONN • SWX
add
Lonza Group AG
Við síðustu lokun
527,20 CHF
Dagbil
526,60 CHF - 530,00 CHF
Árabil
467,80 CHF - 606,00 CHF
Markaðsvirði
37,17 ma. CHF
Meðalmagn
168,16 þ.
V/H-hlutf.
40,93
A/V-hlutfall
0,94%
Aðalkauphöll
SWX
Viðskiptafréttir
Investor's Business Daily
fyrir 4 klukkustundum
Futures Fall In Dangerous Market; Five Titans In Focus
0,099%
2,23%
1,55%
2,27%
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (CHF) | des. 2025info | Breyting á/á |
|---|---|---|
Tekjur | — | — |
Rekstrarkostnaður | — | — |
Nettótekjur | — | — |
Hagnaðarhlutfall | — | — |
Hagnaður á hvern hlut | — | — |
EBITDA | — | — |
Virkt skatthlutfall | — | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (CHF) | des. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 719,00 m. | -57,98% |
Heildareignir | 18,97 ma. | -3,88% |
Heildarskuldir | 9,78 ma. | -5,46% |
Eigið fé alls | 9,19 ma. | — |
Útistandandi hlutabréf | 70,04 m. | — |
Eiginfjárgengi | 4,04 | — |
Arðsemi eigna | — | — |
Ávöxtun eigin fjár | — | — |
Peningaflæði
Breyting á handbæru fé
| (CHF) | des. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | — | — |
Handbært fé frá rekstri | — | — |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | — | — |
Breyting á handbæru fé | — | — |
Frjálst peningaflæði | — | — |
Um
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector. Wikipedia
Framkvæmdastjóri
Stofnsett
1897
Höfuðstöðvar
Vefsvæði
Starfsfólk
19.771
